• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗克洛文强烈抑制发育中的大鼠大脑皮层和神经胶质瘤细胞的复制性 DNA 合成。

Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.

机构信息

Department of Clinical Neuroscience, Huddinge Division of Neurology, Karolinska Institute, Huddinge University Hospital, SE-141 86 Stockholm, Sweden.

出版信息

Invest New Drugs. 2010 Jun;28(3):299-305. doi: 10.1007/s10637-009-9254-4. Epub 2009 Apr 24.

DOI:10.1007/s10637-009-9254-4
PMID:19390782
Abstract

The effects of the cyclin-dependent kinase inhibitors roscovitine and olomoucine on DNA synthesis rate during normal rat brain development were studied by using short time (90 min) incubation. Both purine analogues at 100 microM concentration decreased the DNA synthesis of rat cerebral cortex in an age-dependent manner. The maximum inhibitory effect (approximately 90% for roscovitine, approximately 60% for olomoucine) occurred in rats of 2-13 days postnatal age. In adult rats (> 60 days postnatal age), the effect of both purine analogues was low. Roscovitine even at 200 microM concentration did not inhibit the fraction of DNA synthesis insensitive to hydroxyurea (unscheduled DNA synthesis (UDS)). In addition, in the RG2 rat glioma model, roscovitine produced a strong inhibition of DNA synthesis in glioma cells when compared to adult normal tissue. Since in adult rat brain more than 60% of DNA synthesis is related to DNA repair, usually measured as UDS, our results indicate that roscovitine strongly blocks ongoing DNA synthesis connected with replicative processes.

摘要

本研究采用短期(90 分钟)孵育法,研究了细胞周期蛋白依赖性激酶抑制剂罗洛司汀和olomoucine 对正常大鼠脑发育过程中 DNA 合成速率的影响。嘌呤类似物在 100μM 浓度下,均以年龄依赖性方式降低大鼠大脑皮质的 DNA 合成。罗洛司汀(约 90%)和 olomoucine(约 60%)的最大抑制作用出现在出生后 2-13 天的大鼠中。在成年大鼠(>60 天)中,两种嘌呤类似物的作用较低。即使使用 200μM 浓度的罗洛司汀,也不会抑制对羟基脲不敏感的 DNA 合成分数(非计划 DNA 合成(UDS))。此外,在 RG2 大鼠神经胶质瘤模型中,与成年正常组织相比,罗洛司汀对神经胶质瘤细胞的 DNA 合成有强烈抑制作用。由于在成年大鼠大脑中,超过 60%的 DNA 合成与复制过程相关,通常以 UDS 测量,我们的结果表明,罗洛司汀强烈阻断与复制过程相关的正在进行的 DNA 合成。

相似文献

1
Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.罗克洛文强烈抑制发育中的大鼠大脑皮层和神经胶质瘤细胞的复制性 DNA 合成。
Invest New Drugs. 2010 Jun;28(3):299-305. doi: 10.1007/s10637-009-9254-4. Epub 2009 Apr 24.
2
Early inhibition of DNA synthesis in the developing rat cerebral cortex by the purine analogues olomoucine and roscovitine.
Biochem Biophys Res Commun. 1998 Feb 24;243(3):674-7. doi: 10.1006/bbrc.1998.8157.
3
The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.olomoucine 衍生的合成细胞周期蛋白依赖性激酶抑制剂的放射增敏作用。
Neoplasma. 2010;57(2):161-9. doi: 10.4149/neo_2010_02_161.
4
Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins.由罗司维汀引发的依赖复制的DNA损伤反应会导致DNA复制蛋白解偶联。
Cell Cycle. 2006 Sep;5(18):2153-9. doi: 10.4161/cc.5.18.3235. Epub 2006 Sep 15.
5
Roscovitine inhibits ongoing DNA synthesis in human cervical cancer.罗司维汀抑制人宫颈癌中正在进行的DNA合成。
Cancer Lett. 2002 Jun 6;180(1):7-12. doi: 10.1016/s0304-3835(01)00827-8.
6
Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.罗哌卡因(一种对细胞周期蛋白依赖性激酶cdc2、cdk2和cdk5具有强效且选择性抑制作用的抑制剂)的生化及细胞效应
Eur J Biochem. 1997 Jan 15;243(1-2):527-36. doi: 10.1111/j.1432-1033.1997.t01-2-00527.x.
7
Synthesis and biological activity of olomoucine II.olomoucine II的合成及其生物活性
Bioorg Med Chem Lett. 2002 Nov 18;12(22):3283-6. doi: 10.1016/s0960-894x(02)00693-5.
8
Ongoing DNA synthesis in the rat cerebral cortex is regulated by a proteolytic pathway independent of the proteasome and calpains.大鼠大脑皮层持续的 DNA 合成受一种蛋白水解途径调控,该途径与蛋白酶体和钙蛋白酶无关。
Invest New Drugs. 2010 Jun;28(3):242-50. doi: 10.1007/s10637-009-9238-4. Epub 2009 Mar 17.
9
The cyclin-dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker.细胞周期蛋白依赖性激酶(cdk)抑制剂olomoucine和roscovitine可改变软体动物生物钟起搏器的表达。
Cell Mol Neurobiol. 1997 Oct;17(5):495-507. doi: 10.1023/a:1026358821640.
10
Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors.
J Neurochem. 1998 Apr;70(4):1401-10. doi: 10.1046/j.1471-4159.1998.70041401.x.

引用本文的文献

1
Peptide-Functionalized Nanoparticles-Encapsulated Cyclin-Dependent Kinases Inhibitor Seliciclib in Transferrin Receptor Overexpressed Cancer Cells.转铁蛋白受体过表达癌细胞中肽功能化纳米颗粒包裹的细胞周期蛋白依赖性激酶抑制剂塞利西利布
Nanomaterials (Basel). 2021 Mar 18;11(3):772. doi: 10.3390/nano11030772.
2
Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action.细胞周期蛋白依赖性激酶抑制剂:类型及其作用机制。
Int J Mol Sci. 2021 Mar 10;22(6):2806. doi: 10.3390/ijms22062806.
3
Roscovitine in cancer and other diseases.罗可丁在癌症及其他疾病中的应用。

本文引用的文献

1
Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain.大鼠脑中罗斯考维汀的年龄依赖性药代动力学及其对细胞周期蛋白依赖性激酶5和细胞外信号调节激酶1/2的影响。
Pharmacol Res. 2008 Jul;58(1):32-7. doi: 10.1016/j.phrs.2008.05.010. Epub 2008 Jun 8.
2
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days.一项关于选择性口服细胞周期蛋白依赖性激酶抑制剂塞利西利布(CYC202;R-罗库溴铵)的I期试验,每21天每天给药两次,持续7天。
Br J Cancer. 2007 Jan 15;96(1):29-37. doi: 10.1038/sj.bjc.6603509. Epub 2006 Dec 19.
3
Ann Transl Med. 2015 Jun;3(10):135. doi: 10.3978/j.issn.2305-5839.2015.03.61.
4
Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.心力衰竭时发生改变的中枢神经系统回路:病理生理学及治疗意义
Heart Fail Rev. 2014 Nov;19(6):759-79. doi: 10.1007/s10741-014-9427-x.
5
Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C.长时间接触甲萘醌对神经胶质瘤细胞的杀伤作用:维生素 C 的增强作用。
Invest New Drugs. 2011 Dec;29(6):1314-20. doi: 10.1007/s10637-010-9489-0. Epub 2010 Jul 13.
Replication-dependent DNA damage response triggered by roscovitine induces an uncoupling of DNA replication proteins.
由罗司维汀引发的依赖复制的DNA损伤反应会导致DNA复制蛋白解偶联。
Cell Cycle. 2006 Sep;5(18):2153-9. doi: 10.4161/cc.5.18.3235. Epub 2006 Sep 15.
4
Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives.与罗斯考维汀及其衍生物复合物中的吡哆醛激酶晶体结构。
J Biol Chem. 2005 Sep 2;280(35):31220-9. doi: 10.1074/jbc.M500805200. Epub 2005 Jun 28.
5
Roscovitine targets, protein kinases and pyridoxal kinase.罗斯考维汀的作用靶点包括蛋白激酶和吡哆醛激酶。
J Biol Chem. 2005 Sep 2;280(35):31208-19. doi: 10.1074/jbc.M500806200. Epub 2005 Jun 23.
6
Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.塞利西利布(CYC202,R-罗库溴铵)通过抑制RNA聚合酶II依赖性转录和下调Mcl-1诱导多发性骨髓瘤细胞死亡。
Cancer Res. 2005 Jun 15;65(12):5399-407. doi: 10.1158/0008-5472.CAN-05-0233.
7
Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.细胞周期蛋白依赖性激酶抑制剂发现与开发的最新进展。
Expert Opin Investig Drugs. 2005 Apr;14(4):457-77. doi: 10.1517/13543784.14.4.457.
8
Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat.
Eur J Pharm Sci. 2005 May;25(1):91-103. doi: 10.1016/j.ejps.2005.02.001.
9
Chemical inhibitors of cyclin-dependent kinases.细胞周期蛋白依赖性激酶的化学抑制剂
Trends Cell Biol. 1996 Oct;6(10):393-7. doi: 10.1016/0962-8924(96)10034-9.
10
Protein kinase inhibitors: insights into drug design from structure.蛋白激酶抑制剂:基于结构的药物设计见解
Science. 2004 Mar 19;303(5665):1800-5. doi: 10.1126/science.1095920.